Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling

被引:210
作者
Ausems, MGEM
Verbiest, J
Hermans, MMP
Kroos, MA
Beemer, FA
Wokke, JHJ
Sandkuijl, LA
Reuser, AJJ
van der Ploeg, AT
机构
[1] Univ Utrecht, Med Ctr, Dept Med Genet, NL-3508 AB Utrecht, Netherlands
[2] Erasmus Univ, Acad Hosp, Dept Clin Genet, Rotterdam, Netherlands
[3] Sophia Childrens Univ Hosp, Dept Pediat, Rotterdam, Netherlands
[4] Univ Utrecht, Med Ctr, Dept Neurol, Utrecht, Netherlands
关键词
glycogenosis; Pompe; carrier frequency; genotype frequency;
D O I
10.1038/sj.ejhg.5200367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen storage disease type II (GSD II) is an autosomal recessive myopathy, Early and late-onset phenotypes are distinguished - infantile, juvenile and adult, Three mutations in the acid a-glucosidase gene are common in the Dutch patient population: IVS1(-13F-->G), 525delT and delexon18 63% of Dutch GSD II patients carry one or two of these mutations, and the genotype-phenotype correlation is known, To determine the frequency of GSD II, we have screened an unselected sample of neonates for the occurrence of these three mutations. Based on the calculated carrier frequencies, the predicted frequency of the disease is 1 in 40 000 divided by 1 in 138 000 for infantile G SD II and 1 in 57 000 for adult GSD II. This is about two to four times higher than previously suggested, which is a reason to become more familiar with the presentation of GSD II in its different clinical forms and to adjust the risk assessment for genetic counselling.
引用
收藏
页码:713 / 716
页数:4
相关论文
共 18 条
  • [1] Ausems MGEM, 1996, CLIN GENET, V49, P325
  • [2] Recombinant human acid α-glucosidase:: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice
    Bijvoet, AGA
    Kroos, MA
    Pieper, FR
    Van der Vliet, M
    De Boer, HA
    Van der Ploeg, AT
    Verbeet, MP
    Reuser, AJJ
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (11) : 1815 - 1824
  • [3] BOERKOEL CF, 1995, AM J HUM GENET, V56, P887
  • [4] CHEN YT, 1994, METABOLIC BASIS INHE, P935
  • [5] THE EFFECT OF A SINGLE-BASE PAIR DELETION (DELTA-T525) AND A C1634T MISSENSE MUTATION (PRO545LEU) ON THE EXPRESSION OF LYSOSOMAL ALPHA-GLUCOSIDASE IN PATIENTS WITH GLYCOGEN-STORAGE-DISEASE TYPE-II
    HERMANS, MMP
    DEGRAAFF, E
    KROOS, MA
    MOHKAMSING, S
    EUSSEN, BJ
    JOOSSE, M
    WILLEMSEN, R
    KLEIJER, WJ
    OOSTRA, BA
    REUSER, AJJ
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (12) : 2213 - 2218
  • [6] HIRSCHHORN R, 1994, METABOLIC MOL BASES, P2443
  • [7] HUIE ML, 1994, HUM MOL GENET, V3, P2231
  • [8] A DE-NOVO 13-NT DELETION, A NEWLY IDENTIFIED C647W MISSENSE MUTATION AND A DELETION OF EXON-18 IN INFANTILE ONSET GLYCOGEN-STORAGE-DISEASE TYPE-II (GSDII)
    HUIE, ML
    CHEN, AS
    BROOKS, SS
    GRIX, A
    HIRSCHHORN, R
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (07) : 1081 - 1087
  • [9] Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail
    Kikuchi, T
    Yang, HW
    Pennybacker, M
    Ichihara, N
    Mizutani, M
    Van Hove, JLK
    Chen, YT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 827 - 833
  • [10] GLYCOGEN-STORAGE-DISEASE TYPE-II - FREQUENCY OF 3 COMMON MUTANT ALLELES AND THEIR ASSOCIATED CLINICAL PHENOTYPES STUDIED IN 121 PATIENTS
    KROOS, MA
    VANDERKRAAN, M
    VANDIGGELEN, OP
    KLEIJER, WJ
    REUSER, AJJ
    VANDENBOOGAARD, MJ
    AUSEMS, MGEM
    VANAMSTEL, HKP
    [J]. JOURNAL OF MEDICAL GENETICS, 1995, 32 (10) : 836 - 837